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Abstract 
Limited data are available on the background levels of exposure to synthetic 
pyrethroid (PYR) in Japan despite their frequent application for agriculture and indoor 
extermination and possible effects of chronic and/or low-dose PYR exposure on human 
health.  This study was conducted to describe the level and distribution of one of the 
major PYR metabolites, 3-phenoxybenzoic acid (3-PBA), in urine samples collected 
from a general population in Japan.  The subjects were 535 individuals (184 men and 
351 women; 61.5 ± 9.8 years of age, mean ± S.D.) residing in a town in Hokkaido, a 
dairy and agricultural area.  Urinary 3-PBA was found detectable in 98% of samples 
above the limit of detection of 0.02 μg/L.  The geometric mean values of urinary 
3-PBA in occupationally exposed farmers (n = 87) and the remaining general group 
without occupational exposure (n = 448) were 0.38 μg/L and 0.29 μg/L, respectively, 
ranging from < LOD to 17.09 μg/L.  No significant differences in urinary 3-PBA 
concentrations were shown between these two groups.  Moreover, 3-PBA 
concentrations were found comparable to those reported in some countries.  The 
present study is, to our knowledge, the first report of a biological monitoring study of 
urinary 3-PBA, which elucidated the background environmental exposure level of PYR 
in the Japanese general population without occupational exposure.  Further nationwide 
studies covering different seasons and age distribution are needed to monitor the urinary 
3-PBA levels in Japan. 
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The widespread use of pesticides in agricultural settings, public health, commerce, 
and individual households throughout the world is an indication of the importance of 
these compounds.  According to the official statistics in Japan, annual domestic 
production and import of such pesticides as organophosphorus (OPs), synthetic 
pyrethroids (PYRs), and neonicotinoid amounted to 25,000 and 5,000 tons of active 
components, respectively (Nouyaku-Youran, 2006).  An OECD report revealed that 
Japan’s consumption of pesticides as active component estimated at 1.50 ton/km2 arable 
and permanent cropland in 1990s is much higher than those of other developed 
countries (US; 0.21 ton/km2, Germany; 0.29 ton/km2, Italy; 0.78 ton/km2) (OECD 
Environmental Performance Reviews JAPAN).  Given these estimates about the 
national-level pesticide consumption, the general population in Japan is assumed to be 
exposed to pesticides in higher doses from a variety sources than in other countries.  
Among the classes of widely recognized pesticides, PYRs have today become the 
most frequently used one for non-occupational as well as occupational purposes.  In 
the United States, regulatory phaseout of OPs for residential pest control caused the use 
of PYR to increase since the late 1990s (Current Occupational & Environmental 
Medicine. 4th edition); replacement of OPs with PYRs in residential environments has 
also been observed in Japan.  Thus far, research on PYR toxicity has primarily focused 
on the acute, short-term effect, i.e. prolonged depolarization and hyperexcitation of the 
nervous system caused by its interaction with sodium channels of the axon (Narahashi 
et al., 1982; Tabarean and Narahashi, 2001).  However, the effect of long-term 
exposure to low-level PYRs on human health has been little characterized.  A number 
of epidemiological studies have suggested the relationship between Parkinson’s disease 
(PD) and environmental exposure to pesticides (Tanner and Langston, 1990; Gorell et 
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al., 1998; Priyadarshi et al., 2001); a recent experimental study corroborated the 
possible underlying mechanism that in vivo exposure to PYRs, deltamethrin and 
permethrin, increases dopamine transporter and transporter-mediated dopamine uptake 
in the striatal synaptosome (Elwan et al., 2006).  Also revealed by a recent study was 
the estrogenicity of PYR metabolites (McCarthy et al., 2006).  As a consequence of 
these etiological findings, there has been a growing concern over the association 
between the long-term exposure to PYRs and as-yet-unknown adverse health effects in 
human.  
In the human body, PYRs are metabolized by carboxylesterase, and via further 
metabolization renally excreted in various forms; among them, 3-phenoxybenzoic acid 
(3-PBA) is a non-specific, most frequently detected metabolite of major PYRs including 
permethrin, cypermethrin, deltamethrin, sumithrin, etofenprox and cyhalothrin.  Until 
now, the analytical technique of 3-PBA has become so sophisticated that it can be used 
as a biomarker to assess the level of occupational as well as environmental PYR 
exposure which occurs even in daily activities of life through various routes (ingestion, 
inhalation and dermal absorption). 
In our previous study, 3-PBA has been quantified in the urine of pest control 
operators (PCOs) exposed to PYR during handling, mixing, and spraying (Wang et al., 
2007).  In the absence of data on the urinary 3-PBA levels derived from 
non-occupational PYR exposure, however, we considered that risks resulting from PYR 
exposures among PCOs might not be adequately assessed.  Although some studies 
abroad detected 3-PBA in urine samples of the general population (Becker et al., 2006; 
Schettgen et al., 2002; Heudorf, 2001; Saieva, 2004), to our knowledge no such study 
has been conducted in Japan.  The primary objective of this study is to describe the 
distribution of urinary 3-PBA levels in spot urine samples among different healthy 
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populations in Japan according to gender and age groups.  We then further summarized 
our data to compare with the results available from similar studies conducted on general 
populations in other countries. 
 
2. Materials and methods 
2.1. Study subjects and sample collection 
The study subjects were 184 men and 351 women aged 39-85 recruited from 535 
residents in a rural area of Hokkaido, Japan, who attended a health checkup program in 
August 2005.  Our self-administered questionnaire revealed that 88 subjects have been 
engaged in farm work involving the spraying of pesticides; the mean age ± S.D. of 
farmers and non-farmers was 61.9 ± 9.7 and 61.4 ± 9.9, respectively.  They underwent 
an annual health checkup which included a self-administered questionnaire, a physical 
examination and collection of fasting blood and spot urine samples.  Prior to 
enrollment in the study, an informed consent form was signed by each subject giving the 
right to the use of personal information for research purposes.  The questionnaire 
addressed such lifestyle characteristics as physical activity, smoking status, drinking 
habits, and occupation.  The Ethics Committee of the Nagoya University Graduate 
School of Medicine, Nagoya, Japan approved the study protocol. 
Collected spot urine samples were immediately measured for screening urinalysis 
while the rest were aliquoted into 10 ml polyethylene tubes and shipped daily at -20 oC 
to our laboratory, and then stored at -80 oC until 3-PBA assay. 
 
2.2. Materials 
2-PBA as internal standard (I.S.) and 3-PBA were purchased from Tokyo Kasei 
Kogyo (Tokyo, Japan).  1, 1, 1, 3, 3, 3-Hexafluoroisopropanol (HFIP), 
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N,N-diisopropylcarbodiimide (DIC), tert-butyl-methyl-ether (t-BME), sodium hydrogen 
carbonate and iso-octane were from Sigma-Aldrich (St. Louis, MO, USA).  All other 
reagents were of analytical grade purity. 
 
2.3. 3-PBA analysis 
The concentration of 3-PBA in urine were measured by gas chromatography-mass 
spectrometry (GC/MS) equipped with an electro-ionization system according to a 
method established previously (Leng et al., 2005).  Briefly, 2 ml urine samples were 
transferred in a 15-ml screw-top glass test tube, and 20 μl of I.S. solution (8 mg 2-PBA 
/ml of acetonitrile) and 0.5 ml of 6 mol/L HCl were added.  After gentle shaking, the 
test tube was incubated at 100 oC in a heat block for hydrolyzation.  After cooling the 
test tubes on ice, 4 ml of tert-butyl-methyl-ether was added, and the mixture was shaken 
vigorously for 10 min and centrifuged for 5 min at 2,000 × g.  The organic phase 
(upper layer) was transferred in a new screw cap test tube.  The residuals were 
re-extracted with 4 ml of tert-butyl-methyl-ether, shaken and centrifuged.  The 
supernatant obtained from second extraction was combined with the first extract.  The 
resulting extract was evaporated at 45 oC (heat block) to dryness with a gentle nitrogen 
stream.  The residue was dissolved in 250 μl acetonitrile.  For derivatization, 30 μl of 
HFIP and 20 μl DIC was added and incubated for 10 min at room temperature.  Then, 
1 ml of a 1 mol/l sodium hydrogencarbonate solution and 250 μl iso-octane was added.  
The test tube was shaken vigorously and centrifuged for 5 min at 2,000 × g.  One μL 
of the iso-octane phase was injected into GC/MS. 
Analyses of 3-PBA were performed on Agilent 5975 inert MSD system.  The GC 
operating conditions were as follows: GC column, HP-5MS (Agilent, USA), 30 m × 
0.25-mm i.d., 0.25-μm film thickness; column temperatures, 70 oC (1 min)-15 oC 
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/min-300 oC (6 min); injection port temperature, 250 oC; carrier gas, helium (99.999% 
purity); flow rate, 1 ml/min.  The injection volume was 1 μl.  Splitless was changed 
to split 15:1 at 2 min after sample injection.  The MS operating conditions were as 
follows: ionization source temperature, 230 oC; electron ionization, 70 eV; interface 
temperature, 300 oC.  All urinary creatinine levels were measured according to the 
Jaffé reaction. 
 
2.4. Quality control materials 
Two “Quality Control” urine samples were used in the urinary 3-PBA assay.  The 
urine samples from 3 healthy volunteers (students of Nagoya University, 22-29 years) 
were collected and pooled for “quality control” urine, then, standard 3-PBA solution 
dissolved in acetonitrile was added.  Consequently, the final concentration of 3-PBA in 
quality control urine was estimated to be 2.3 and 46.9 μg/L using above mentioned 
measurement technique.  These quality control urine samples were stored at -80 oC 
until analysis, and analyzed every 18 samples.  The method of urinary 3-PBA analysis 
used in this study showed good reproducibility on a 10-replicate measurement of pooled 
control urine (intra-assay coefficient of variation of 5% with 2.3 μg/L and 8% with 46.9 
μg/L), sensitivity (LOD = 0.02 μg/L, signal to noise ratio = 1:10), and relative recovery 
(98%), and thus was considered to be suitable for routine analysis. 
. 
2.5. Statistical analysis 
Deviation from the normality of the data distribution was examined using a 
Kolmogorov- Smirnov test.  Mann-Whitney U test and Kruskal-Wallis test were used 
to examine the differences in urinary 3-PBA concentrations between men and women 
and between 3 age groups (40-49, 50-69, 70-85), respectively.  All statistical analysis 
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was conducted using the SPSS statistical package for Windows version 11.0J (SPSS Inc., 
Chicago, IL), and 2-sided p values of < 0.05 were considered statistically significant.  
Undetectable urinary 3-PBA concentrations were estimated as half the limit of detection 
(LOD) value (Finkelstein et al., 2001). 
 
3. Results 
Detection rates (> LOD) were 98% for non-farming group and 99% for farming 
group.  The urinary creatinine concentration in men (1.24 ± 0.69 g/L) was significantly 
higher than in women (0.80 ± 0.58 g/L).  Both the distribution of uncorrected 3-PBA 
(μg/L) and creatinine-corrected 3-PBA (3-PBAcre) concentrations (μg/g of creatinine) in 
the non-farming group are presented in Table 1.  The Kolmogorov-Smirnov test 
indicated that the distribution of 3-PBAcre was logarithmically normal.  Urinary 3-PBA 
concentrations were not significantly different between 3 age groups, but the 3-PBAcre 
value in women was significantly higher than that in men.  Table 2 presents the 
distribution of 3-PBA and 3-PBAcre values in the farming group.  There were no 
significant differences in urinary 3-PBA concentrations between genders or age groups.  
Table 3 summarizes the results of previous studies, which reported urinary 3-PBA 
concentrations in general populations.  The geometric mean (GM) of 3-PBA in 
non-farmers group in our population was close to that in Third National Report on 
Human Exposure to Environmental Chemicals (CDC 2005) and GerES IV Pilot study 
(Becker et al., 2006).  Mean value of 3-PBA reported by Leng et al (2005) was 0.37 ± 
0.77 μg/L, which is slightly lower than that in the non-farming group of our population 
(0.63 ± 1.34 μg/L).  Mean value of 3-PBA reported by Saieva et al. (2004) was much 




This study merits attention in that it provided descriptive data concerning the 
distribution of urinary PYR metabolites in the healthy general population for the first 
time in Japan.  The method for determining metabolites in the urine used in this study 
was the most practical and widely used one to estimate the internal doses of PYRs; this 
facilitated the comparison of the urinary 3-PBA concentrations obtained in our 
population with those reported abroad in regard to their distribution. 
Obvious advantages of urine samples for biological monitoring of the metabolites are 
the ease of sample collection, dense concentration of the metabolite, and the greater 
number of samples available for analysis compared to blood samples.  The detection of 
this metabolite in urine of the general population might reflect exposure to various 
PYRs via dietary intake and from residential environments.  We supposed that, 
considering the non-specific nature of 3-PBA, the importance of its use as a monitoring 
marker is not to specify the sources and routes of the exposure which are usually diverse 
and hardly distinguishable, but to assess the overall PYR exposure levels covering all 
routes. 
In our previous study, the GM of 3-PBA levels in urine collected from Japanese pest 
control operators in summer was 12.2 μg/g creatinine (Wang et al., 2007), > 30-fold 
higher than GMs obtained in the present study.  These results clearly indicated 
dramatically high levels of exposure among pest control operators in comparison with 
the non-spraying population.  However, our study population showed no statistical 
difference in GM of 3-PBA between the farmers and non-farmers.  Although no direct 
exposure assessment tool was incorporated in this study and hence the reason for this 
lack of difference remains unclear, we speculated that factors such as the pesticide 
application method or work practice peculiar to this area of the study might contribute; 
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the majority of the pesticide sprayers among our subjects were engaged in dairy farming, 
which involved much less frequent handling and spraying opportunities in summertime 
than pest control operators who usually work in indoor environments filled with mist or 
vapor of sprayed pesticides. 
Barr et al (2007) performed a cross validation study between two methodological 
techniques for measurement of 3-PBA (Leng et al., 2005; Baker et al., 2004) and 
concluded that both methods produced comparable analytical results on urine samples at 
unknown concentrations.  The most salient finding of our study is that the GM of 
3-PBA levels of our subjects was virtually identical to those of a U.S. population (0.32 
μg/L) and German population (0.34 μg/L).  Saieva et al. (2004) reported much higher 
24-hour urinary 3-PBA GMs of 0.88 μg/day for 51 Italians who live in the urban area 
(Florence) and 0.71 μg/day for 18 Italians who live in the rural area (Ragusa).  Some 
precautions regarding the concentration unit of the metabolites (μg/day v.s. μg/g of 
creatinine) should be paid in the comparison of these results.  Since the amount of 
creatinine excreted per day was assumed to vary around one gram, comparison of these 
data indicated that ≈ 3-fold variations of the urinary 3-PBA concentration even between 
low-level exposure populations are highly likely.  In addition, the LOD levels differed 
greatly from study to study; although our study achieved a high detection rate, high 
level of LOD would result in low detection rate and cause the population distribution of 
the 3-PBA concentrations to heavily skew, undermining the appropriate characterization 
of PYR exposure in the general population.  
We have estimated per cropland PYR shipment in 2005 at 1.72 kg/km2 and 3.42 
kg/km2 in Hokkaido and all parts of Japan, respectively (cropland data were obtained 
from the Ministry of Agriculture, Forestry and Fisheries of Japan).  These estimations 
implied that people who live in Hokkaido have generally been less exposed to 
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environmental PYR than average Japanese, though other information is lacking on 
exposures through drinking water, air, dust, and circulation of food products, both 
domestic and imported, in the market.  We believe that the monitoring of urinary 
3-PBA in other areas in Japan is to be conducted to help establish reliable reference 
data; moreover, seasonal variations of the monitoring data should also be cautiously 
considered. 
Several limitations should be mentioned.  This study presented only 3-PBA data, 
unlike previous NHANES and GerES IV pilot studies which have measured such PYR 
metabolite as cis- and 
trans-3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropane-1-carbocylic acid (DCCA), 
3-(2,2-dibromovinyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid (DBCA) and 
4-fluoro-3-phenoxybenzoic acid (F-PBA) in general populations.  However, the 
NHANES study indicated that F-BPA and DBCA were less frequently detected in the 
general population (< 30% and < 50%, respectively); moreover, we found that DCCA 
measurement conducted in our laboratory was not as technically reliable as 3-PBA 
measurement.  Second, creatinine-correction of urinary metabolites might overestimate 
the 3-PBA in women because urinary creatinine levels depend on the volume of muscle 
bulk.  If so, the statistically significant difference in urinary 3-PBA levels between men 
and women may be misleading, and comparison of 3-PBA concentrations in the spot 
urine samples should be limited within a particular gender or age group.     
In summary, despite one sample collection area and spot urine, the present study is 
the first to report that PYR metabolite 3-PBA measurement in urine was performed for a 
large general population and occupationally-exposed group in Japan.  Our findings of a 
similar level of Japanese urinary 3-PBA to that in previous studies indicated that the 
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